Clinical trial
Insulin Sensitivity in Men With the Metabolic Syndrome
NCT00433173 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Suspended
Key facts
| NCT number | NCT00433173 |
|---|---|
| Title | Insulin Sensitivity in Men With the Metabolic Syndrome |
| Official title | Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | American Diabetes Association |
| Status | Suspended |
| Study type | Interventional |
| Conditions | Metabolic Syndrome |
| Intervention type | Drug, Procedure |
| Interventions | intravenous glucose tolerance test, testosterone, anastrozole, goserelin acetate implant, aerobic capacity (VO2 Max), MRI, muscle biopsy, measurement of resting metabolic rate (energy expenditure), Dual energy x-ray absorptiometry, Fasting oral glucose tolerance test |
| Enrollment | 72 |
| Start date | May 1, 2006 |
| Primary completion | Feb 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Feb 9, 2007 |
| Last update posted | Mar 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: